In an effort to find alternative therapeutic interventions to combat tuberculosis, a better understanding of the pathophysiology of Mycobacterium tuberculosis is required. The Mycobacterium tuberculosis curli pili (MTP) adhesin, present on the surface of this pathogen, has previously been shown using functional genomics and global transcriptomics, to play an important role in establishing infection, bacterial aggregation, and modulating host response in vitro and in vivo.
This investigation aimed to determine the role of MTP in modulating the metabolism of M. tuberculosis, using mtp gene-knockout mutant and complemented strains.
Untargeted two-dimensional gas chromatography time-of-flight mass spectrometry, and bioinformatic analyses, were used to identify significant differences in the metabolite profiles among the wild-type, ∆mtp mutant and mtp-complemented strains, and validated with results generated by real-time quantitative PCR.
A total of 28 metabolites were found to be significantly altered when comparing the ∆mtp mutant and the wild-type strains indicating a decreased utilisation of metabolites in cell wall biogenesis, a reduced efficiency in the breakdown of fatty acids, and decreased amino acid biosynthesis in the former strain. Comparison of the wild-type to mtp-complement, and ∆mtp to mtp-complemented strains revealed 10 and 16 metabolite differences, respectively. Real-time quantitative PCR results supported the metabolomics findings. Complementation of the ∆mtp mutant resulted in a partial restoration of MTP function.
The lack of the MTP adhesin resulted in various bacterial cell wall alterations and related metabolic changes. This study highlights the importance of MTP as a virulence factor and further substantiates its potential use as a suitable biomarker for the development of diagnostic tools and intervention therapeutics against TB.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
The datasets generated during and/or analysed during the current study are not publicly available due to collaborative purposes and future publications but are available from the corresponding author on reasonable request. KEGG database reported in this study is accessible via [https://www.genome.jp/kegg/].
Alderwick, L. J., Harrison, J., Lloyd, G. S., & Birch, H. L. (2015). The mycobacterial cell wall-peptidoglycan and arabinogalactan. Cold Spring Harbor Perspectives in Medicine, 5(8), a021113–a021113.
Alteri, C. J., Xicohténcatl-Cortes, J., Hess, S., Caballero-Olín, G., Girón, J. A., & Friedman, R. L. (2007). Mycobacterium tuberculosis produces pili during human infection. Proceedings of the National Academy of Sciences, 104(12), 5145–5150.
Angala, S. K., Belardinelli, J. M., Huc-Claustre, E., Wheat, W. H., & Jackson, M. (2014). The cell envelope glycoconjugates of Mycobacterium tuberculosis. Critical Reviews in Biochemistry and Molecular Biology, 49(5), 361–399.
Azuma, I., Ajisaka, M., & Yamamura, Y. (1970). Polysaccharides of Mycobacterium bovis Ushi 10, Mycobacterium smegmatis, Mycobacterium phlei, and atypical Mycobacterium P1. Infection and Immunity, 2(3), 347–349.
Bardarov, S., Bardarov, S., Jr., Pavelka, M. S., Jr., Sambandamurthy, V., Larsen, M., Tufariello, J., et al. (2002). Specialized transduction: an efficient method for generating marked and unmarked targeted gene disruptions in Mycobacterium tuberculosis, M. bovis BCG and M. smegmatis. Microbiology, 148(10), 3007–3017.
Bermudez, L. E., & Goodman, J. (1996). Mycobacterium tuberculosis invades and replicates within type II alveolar cells. Infection and Immunity, 64(4), 1400–1406.
Beste, D. J., Nöh, K., Niedenführ, S., Mendum, T. A., Hawkins, N. D., Ward, J. L., et al. (2013). 13C-flux spectral analysis of host-pathogen metabolism reveals a mixed diet for intracellular Mycobacterium tuberculosis. Chemistry and Biology, 20, 1012–1021.
Beukes, D., Du Preez, I., & Loots, D. T. (2019). Total metabolome extraction from mycobacterial cells for GC-MS metabolomics analysis. Microbial Metabolomics, 1859, 121–131.
Brennan, P. J., & Nikaido, H. (1995). The envelope of mycobacteria. Annual Review of Biochemistry, 64, 29–63.
Bruning, J. B., Murillo, A. C., Chacon, O., Barletta, R. G., & Sacchettini, J. C. (2011). Structure of the Mycobacterium tuberculosis D-alanine:D-alanine ligase, a target of the antituberculosis drug D-cycloserine. Antimicrobial Agents and Chemotherapy, 55(1), 291–301.
Buckoreelall, K., Sun, Y., Hobrath, J. V., Wilson, L., & Parker, W. B. (2012). Identification of Rv0535 as methylthioadenosine phosphorylase from Mycobacterium tuberculosis. Tuberculosis (Edinburgh), 92(2), 139–147.
Bussi, C., & Gutierrez, M. G. (2019). Mycobacterium tuberculosis infection of host cells in space and time. FEMS Microbiology Reviews, 43(4), 341–361.
Cha, D., Cheng, D., Liu, M., Zeng, Z., Hu, X., & Guan, W. (2009). Analysis of fatty acids in sputum from patients with pulmonary tuberculosis using gas chromatography-mass spectrometry preceded by solid-phase microextraction and post-derivatization on the fiber. Journal of Chromatography A, 1216, 1450–1457.
Chou, S., Chedore, P., & Kasatiya, S. (1998). Use of gas chromatographic fatty acid and mycolic acid cleavage product determination to differentiate among Mycobacterium genavense, Mycobacterium fortuitum, Mycobacterium simiae, and Mycobacterium tuberculosis. Journal of Clinical Microbiology, 36(2), 577–579.
Chow, E. D., & Cox, J. S. (2011). TB lipidomics—the final frontier. Chemistry and Biology, 18(12), 1517–1518.
Collins, J. M., Walker, D. I., Jones, D. P., Tukvadze, N., Liu, K. H., Tran, V. T., et al. (2018). High-resolution plasma metabolomics analysis to detect Mycobacterium tuberculosis-associated metabolites that distinguish active pulmonary tuberculosis in humans. PLoS ONE, 13(10), e0205398.
Completo, G., & Lowary, T. (2008). Synthesis of galactofuranose-containing acceptor substrates for mycobacterial galactofuranosyltransferases. Journal of Organic Chemistry, 73(12), 4513–4525.
Cook, G. M., Berney, M., Gebhard, S., Heinemann, M., Cox, R. A., Danilchanka, O., et al. (2009). Physiology of mycobacteria. Advances in Microbial Physiology, 55, 81–319.
Csonka, L. N. (1989). Physiological and genetic responses of bacteria to osmotic stress. Microbiological Reviews, 53(1), 121–147.
de Carvalho, L. P., Fischer, S. M., Marrero, J., Nathan, C., Ehrt, S., & Rhee, K. Y. (2010). Metabolomics of Mycobacterium tuberculosis reveals compartmentalized co-catabolism of carbon substrates. Chemistry and Biology, 17, 1122–1131.
Dlamini, M. T. (2017). Whole transcriptome analysis to elucidate the role of MTP in gene regulation of pulmonary epithelial cells infected with Mycobacterium tuberculosis. Masters thesis. University of KwaZulu-Natal. Durban.
Dunn, J., & Grider, M. H. (2020). Physiology, adenosine triphosphate (ATP). [Updated 2020 Jan 15]. In: StatPearls [Internet].
Early, J. V., Casey, A., Martinez-Grau, M. A., Gonzalez Valcarcel, I. C., Vieth, M., Ollinger, J., et al. (2016). Oxadiazoles have butyrate-specific conditional activity against Mycobacterium tuberculosis. Antimicrobial agents and chemotherapy, 60(6), 3608–3616.
Eoh, H. (2014). Metabolomics: a window into the adaptive physiology of Mycobacterium tuberculosis. Tuberculosis, 94(6), 538–543.
Etienne, G., Malaga, W., Laval, F., Lemassu, A., Guilhot, C., & Daffé, M. (2009). Identification of the polyketide synthase involved in the biosynthesis of the surface-exposed lipooligosaccharides in mycobacteria. Journal of Bacteriology, 191(8), 2613–2621.
Forrellad, M. A., Klepp, L. I., Gioffré, A., Sabio y García, J., Morbidoni, H. R., de la Paz Santangelo, M., et al. (2013). Virulence factors of the Mycobacterium tuberculosis complex. Virulence, 4(1), 3–66.
Gandhi, N. R., Moll, A., Sturm, A. W., Pawinski, R., Govender, T., Lalloo, U., et al. (2006). Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. The Lancet, 368(9547), 1575–1580.
Halouska, S., Fenton, R. J., Zinniel, D. K., Marshall, D. D., Barletta, R. G., & Powers, R. (2014). Metabolomics analysis identifies d-alanine-d-alanine ligase as the primary lethal target of d-cycloserine in mycobacteria. Journal of Proteome Research, 13(2), 1065–1076.
Jantzen, E., Tangen, T., & Eng, J. (1989). Gas chromatography of mycobacterial fatty acids and alcohols: diagnostic applications. Apmis, 97(11), 1037–1045.
Joe, M., & Lowary, T. (2016). Synthesis of a homologous series of galactofuranose-containing mycobacterial arabinogalactan fragments. Canadian Journal of Chemistry, 94(11), 976–988.
Kamio, Y., Itoh, Y., & Terawaki, Y. (1981). Chemical structure of peptidoglycan in Selenomonas ruminantium: cadaverine links covalently to the D-glutamic acid residue of peptidoglycan. Journal of Bacteriology, 146(1), 49–53.
Kanehisa, M., Furumichi, M., Tanabe, M., Sato, Y., & Morishima, K. (2017). KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Research, 45(D1), D353–D361.
Kim, S., Chen, J., Cheng, T., Gindulyte, A., He, J., He, S., et al. (2019). PubChem 2019 update: improved access to chemical data. Nucleic Acids Research, 47(D1), D1102–D1109.
Kinsella, R. J., Fitzpatrick, D. A., Creevey, C. J., & McInerney, J. O. (2003). Fatty acid biosynthesis in Mycobacterium tuberculosis: lateral gene transfer, adaptive evolution, and gene duplication. Proceedings of the National Academy of Sciences of the United States of America, 100(18), 10320–10325.
Kline, K. A., Fälker, S., Dahlberg, S., Normark, S., & Henriques-Normark, B. (2009). Bacterial adhesins in host-microbe interactions. Cell Host and Microbe, 5(6), 580–592.
Landaas, S. (1975). Accumulation of 3-hydroxyisobutyric acid, 2-methyl-3-hydroxybutyric acid and 3-hydroxyisovaleric acid in ketoacidosis. International Journal of Clinical Chemistry, 64(2), 143–154.
Larsen, M. H., Biermann, K., Tandberg, S., Hsu, T., & Jacobs, W. R., Jr. (2007). Genetic manipulation of Mycobacterium tuberculosis. Current Protocols in Microbiology, 6(1), 10A–A12.
Lau, S. K., Lam, C. W., Curreem, S. O., Lee, K. C., Lau, C. C., Chow, W. N., et al. (2015). Identification of specific metabolites in culture supernatant of Mycobacterium tuberculosis using metabolomics: exploration of potential biomarkers. Emerging Microbes and Infections, 4(1), e6.
Loots, D. T. (2014). An altered Mycobacterium tuberculosis metabolome induced by katG mutations resulting in isoniazid resistance. Antimicrobial Agents and Chemotherapy, 58(4), 2144–2149.
Loots, D. T., Swanepoel, C. C., Newton-Foot, M., & Gey van Pittius, N. C. (2016). A metabolomics investigation of the function of the ESX-1 gene cluster in mycobacteria. Microbial Pathogenesis, 100, 268–275.
Mahapatra, S., Hess, A. M., Johnson, J. L., Eisenach, K. D., DeGroote, M. A., Gitta, P., et al. (2014). A metabolic biosignature of early response to anti-tuberculosis treatment. BMC Infectious Diseases, 14(1), 53.
Meissner-Roloff, R. J., Koekemoer, G., & Warren, R. M. (2012). A metabolomics investigation of a hyper-and hypo-virulent phenotype of Beijing lineage M. tuberculosis. Metabolomics, 8(6), 1194–1203.
Meissner-Roloff, R. J., Newton-Foot, M., & van Pittius, N. C. G. (2013). A metabolomics approach exploring the function of the ESX-3 type VII secretion system of M. smegmatis. Metabolomics, 9(3), 631–641.
Mikusová, K., Huang, H., Yagi, T., Holsters, M., Vereecke, D., D'Haeze, W., et al. (2005). Decaprenylphosphoryl arabinofuranose, the donor of the D-arabinofuranosyl residues of mycobacterial arabinan, is formed via a two-step epimerization of decaprenylphosphoryl ribose. Journal of Bacteriology, 187(23), 8020–8025.
Mirsaeidi, M., Banoei, M. M., Winston, B. W., & Schraufnagel, D. E. (2015). Metabolomics: applications and promise in mycobacterial disease. Annals of the American Thoracic Society, 12(9), 1278–1287.
Naidoo, N., Ramsugit, S., & Pillay, M. (2014). Mycobacterium tuberculosis pili (MTP), a putative biomarker for a tuberculosis diagnostic test. Tuberculosis, 94(3), 338–345.
Naidoo, N., Pillay, B., Bubb, M., Pym, A., Chiliza, T., Naidoo, K., et al. (2018). Evaluation of a synthetic peptide for the detection of anti-Mycobacterium tuberculosis curli pili IgG antibodies in patients with pulmonary tuberculosis. Tuberculosis (Edinburgh, Scotland), 109, 80–84.
Namanja-Magliano, H. A., Evans, G. B., Harijan, R. K., Tyler, P. C., & Schramm, V. L. (2017). Transition state analogue inhibitors of 5'-deoxyadenosine/5'-methylthioadenosine nucleosidase from Mycobacterium tuberculosis. Biochemistry, 56(38), 5090–5098.
Neely, M. N., & Olson, E. R. (1996). Kinetics of expression of the Escherichia coli cad operon as a function of pH and lysine. Journal of Bacteriology, 178(18), 5522–5528.
Nyawo, G. (2016). The role of Mycobacterium tuberculosis pili in pathogenesis: growth and survival kinetics, gene regulation and host immune response, and in vitro growth kinetics. Masters thesis. University of KwaZulu-Natal. Durban.
Patel, K. N., Patel, J. K., Patel, M. P., Rajput, G. C., & Patel, H. A. (2010). Introduction to hyphenated techniques and their applications in pharmacy. Pharmaceutical Methods, 1(1), 2–13.
Pathak, A. K., Pathak, V., Riordan, J. M., Gurcha, S. S., Besra, G. S., & Reynolds, R. C. (2004). Synthesis of mannopyranose disaccharides as photoaffinity probes for mannosyltransferases in Mycobacterium tuberculosis. Carbohydrate Research, 339(3), 683–691.
Ramachandran, S., Fontanille, P., Pandey, A., & Larroche, C. (2006). Gluconic acid: Properties, applications and microbial production. Food Technology & Biotechnology, 44(2), 185–195.
Ramakrishnan, T., Murthy, P. S., & Gopinathan, K. P. (1972). Intermediary metabolism of mycobacteria. Bacteriological Reviews, 36(1), 65–108.
Ramsugit, S., Guma, S., Pillay, B., Jain, P., Larsen, M. H., Danaviah, S., et al. (2013). Pili contribute to biofilm formation in vitro in Mycobacterium tuberculosis. Antonie van Leeuwenhoek, 104(5), 725–735.
Ramsugit, S., & Pillay, M. (2014). Mycobacterium tuberculosis pili promote adhesion to and invasion of THP-1 macrophages. Japanese Journal of Infectious Diseases, 67(6), 476–478.
Ramsugit, S., Pillay, B., & Pillay, M. (2016). Evaluation of the role of Mycobacterium tuberculosis pili (MTP) as an adhesin, invasin, and cytokine inducer of epithelial cells. The Brazilian Journal of Infectious Diseases, 20(2), 160–165.
Rogacki, M. K., Pitta, E., Balabon, O. B., Huss, S., Lopez-Roman, E. M., Argyrou, A., et al. (2018). Identification and profiling of hydantoins—A novel class of potent antimycobacterial DprE1 inhibitors. Journal of Medicinal Chemistry, 61(24), 11221–11249.
Samartzidou, H., & Delcour, A. H. (1998). E. coli PhoE porin has an opposite voltage-dependence to the homologous OmpF. The Embo Journal, 17(1), 93–100.
Sancho-Vaello, E., Albesa-Jové, D., Rodrigo-Unzueta, A., & Guerin, M. E. (2017). Structural basis of phosphatidyl-myo-inositol mannosides biosynthesis in mycobacteria. Biochimica et Biophysica Acta, 1862(11), 1355–1367.
Schaefer, W. B., & Lewis, C. W., Jr. (1965). Effect of oleic acid on growth and cell structure of mycobacteria. Journal of Bacteriology, 90(5), 1438–1447.
Schleifer, K. H., & Kandler, O. (1972). Peptidoglycan types of bacterial cell walls and their taxonomic implications. Bacteriological Reviews, 36(4), 407–477.
Schymanski, E. L., Jeon, J., Gulde, R., Fenner, K., Ruff, M., Singer, H. P., et al. (2014). Identifying small molecules via high resolution mass spectrometry: communicating confidence. Environmental Science and Technology, 48, 2097–2098.
Smith, I. (2003). Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence. Clinical Microbiology Reviews, 16(3), 463–496.
Stones, D. H., & Krachler, A. M. (2015). Fatal attraction: how bacterial adhesins affect host signaling and what we can learn from them. International Journal of Molecular Sciences, 16(2), 2626–2640.
Sullivan, G. M., & Feinn, R. (2012). Using effect size—or why the P value is not enough. Journal of Graduate Medical Education, 4(3), 279–282.
Swanepoel, C. C., & Loots, D. T. (2014). The use of functional genomics in conjunction with metabolomics for Mycobacterium tuberculosis research. Disease Markers, 2014, 124218.
Titgemeyer, F., Amon, J., Parche, S., Mahfoud, M., Bail, J., Schlicht, M., et al. (2007). A genomic view of sugar transport in Mycobacterium smegmatis and Mycobacterium tuberculosis. Journal of Bacteriology, 189(16), 5903–5915.
Tripathi, D., Chandra, H., & Bhatnagar, R. (2013). Poly-L-glutamate/glutamine synthesis in the cell wall of Mycobacterium bovis is regulated in response to nitrogen availability. BMC Microbiology, 13, 226.
van den Berg, R. A., Hoefsloot, H. C., Westerhuis, J. A., Smilde, A. K., & van der Werf, M. J. (2006). Centering, scaling, and transformations: improving the biological information content of metabolomics data. BMC Genomics, 7(1), 142.
Vilkas, E., & Lederer, E. (1960). On the structure of phosphatidylinosito-dimannoside of Mycobacterium tuberculosis. Bulletin de Societe Chimique Biologique (Paris), 42, 1013–1022.
Warner, D. F. (2014). Mycobacterium tuberculosis metabolism. Cold Spring Harbor Perspectives in Medicine, 5(4), a021121.
Wesener, D. A., Levengood, M. R., & Kiessling, L. L. (2017). Comparing galactan biosynthesis in Mycobacterium tuberculosis and Corynebacterium diphtheriae. Journal of Biological Chemistry, 292(7), 2944–2955.
World Health Organization (2019). WHO 2018 Global Statistics Report. Retrieved November 30, 2019. https://www.who.int/tb/publications/global_report/en/.
Zelante, T., Fallarino, F., Bistoni, F., Puccetti, P., & Romani, L. (2009). Indoleamine 2,3-dioxygenase in infection: The paradox of an evasive strategy that benefits the host. Microbes and Infection, 11(1), 133–141.
Zhang, L., Alfano, J. R., & Becker, D. F. (2015). Proline metabolism increases katG expression and oxidative stress resistance in Escherichia coli. Journal of Bacteriology, 197(3), 431–440.
Zhang, Y. J., Reddy, M. C., Ioerger, T. R., Rothchild, A. C., Dartois, V., Schuster, B. M., et al. (2013). Tryptophan biosynthesis protects mycobacteria from CD4 T-cell-mediated killing. Cell, 155(6), 1296–1308.
Zhong, L., Zhou, J., Chen, X., & Yin, Y. (2016). Serum metabolomic study for the detection of candidate biomarkers of tuberculosis. International Journal Of Clinical And Experimental Pathology, 9(3), 3256–3266.
This study was funded by MP’s South African National Research Foundation CPRR grant 105841 Grantholder-linked bursary and project running costs, and a University of KwaZulu-Natal College of Health Sciences scholarship.
Conflict of interest
SA declares that she has no conflict of interest. KSR declares that she has no conflict of interest. SS declares he has no conflict of interest. DLT declares he has no conflict of interest. DB declares she has no conflict of interest. MVR declares she has no conflict of interest. BP declares he has no conflict of interest. MP declares she has no conflict of interest.
The study was approved by the University of KwaZulu-Natal Biomedical Research Ethics Committee (BE254/17 and BE255/17).
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
About this article
Cite this article
Ashokcoomar, S., Reedoy, K.S., Senzani, S. et al. Mycobacterium tuberculosis curli pili (MTP) deficiency is associated with alterations in cell wall biogenesis, fatty acid metabolism and amino acid synthesis. Metabolomics 16, 97 (2020). https://doi.org/10.1007/s11306-020-01720-z
- M. tuberculosis curli pili
- GC × GC-TOFMS